Invenomic Capital Management’s Caesarstone CSTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,046
| Closed | -$147K | – | 166 |
|
|
2024
Q1 | $147K | Sell |
36,046
-233,288
| -87% | -$954K | 0.01% | 145 |
|
|
2023
Q4 | $1.01M | Sell |
269,334
-103,422
| -28% | -$387K | 0.05% | 153 |
|
|
2023
Q3 | $1.6M | Buy |
372,756
+15,609
| +4% | +$66.8K | 0.07% | 134 |
|
|
2023
Q2 | $1.87M | Sell |
357,147
-99,403
| -22% | -$521K | 0.09% | 119 |
|
|
2023
Q1 | $1.89M | Buy |
456,550
+10,583
| +2% | +$43.7K | 0.11% | 123 |
|
|
2022
Q4 | $2.55M | Sell |
445,967
-39,496
| -8% | -$226K | 0.17% | 113 |
|
|
2022
Q3 | $4.52M | Sell |
485,463
-17,106
| -3% | -$159K | 0.39% | 83 |
|
|
2022
Q2 | $4.59M | Buy |
502,569
+2,811
| +0.6% | +$25.7K | 0.33% | 80 |
|
|
2022
Q1 | $4.2M | Buy |
499,758
+142,473
| +40% | +$1.2M | 0.45% | 63 |
|
|
2021
Q4 | $4.05M | Buy |
357,285
+98,925
| +38% | +$1.12M | 0.87% | 39 |
|
|
2021
Q3 | $3.21M | Buy |
258,360
+66,659
| +35% | +$828K | 1.04% | 30 |
|
|
2021
Q2 | $2.83M | Sell |
191,701
-53,459
| -22% | -$789K | 0.68% | 30 |
|
|
2021
Q1 | $3.37M | Buy |
245,160
+17,558
| +8% | +$241K | 0.75% | 19 |
|
|
2020
Q4 | $2.93M | Buy |
227,602
+120,712
| +113% | +$1.56M | 0.75% | 13 |
|
|
2020
Q3 | $1.05M | Buy |
106,890
+67,096
| +169% | +$658K | 0.58% | 46 |
|
|
2020
Q2 | $472K | Buy |
39,794
+12,559
| +46% | +$149K | 0.35% | 87 |
|
|
2020
Q1 | $288K | Buy |
+27,235
| New | +$288K | 0.24% | 99 |
|